• DESLANOSIDE chembl:CHEMBL1614 Approved

    Alternate Names:

    CEDILANID-D
    DESLANOSIDE
    DESACETYL-LANATOSIDE C
    DESACETYLLANATOSIDE C
    DESLANOSIDUM
    CEDILANID-D (TN)
    DEACETYLLANATOSIDE C
    GLUCODIGOXIN
    (3BETA,5BETA,12BETA)-3-{[BETA-D-GLUCOPYRANOSYL-(1->4)-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL-(1->4)-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL-(1->4)-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-12,14-DIHYDROXYCARD-20(22)-ENOLIDE
    3-[(O-BETA-D-GLUCOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL)OXY]-12,14-DIHYDROXY-3BETA,5BETA,12BETA-CARD-20(22)-ENOLIDE
    DESLANOSIDO
    CEDILANIDEĀ®
    chembl:CHEMBL1614
    drugbank:01078
    pubchem.compound:28620
    chemidplus:17598-65-1
    rxcui:3248

    Drug Info:

    FDA Approval Approved before 1982
    Drug Class small molecule
    Drug Indications Cardiotonic Agents
    Drug Indications Antiarrhythmia Agents
    Year of Approval approved before 1982
    Drug Class cardiotonic agents
    Drug Class anti-arrhythmia agents
    (2 More Sources)
  • Interaction Score: 3.43

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Novel drug target Established target
    Trial Name -
    Mechanism of Interaction Sodium/potassium-transporting ATPase inhibitor

  • Interaction Score: 1.72

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction Sodium/potassium-transporting ATPase inhibitor
    Direct Interaction yes

    PMIDs:
    None found


  • Interaction Score: 1.72

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction Sodium/potassium-transporting ATPase inhibitor
    Direct Interaction yes

    PMIDs:
    None found


  • Interaction Score: 1.72

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Sodium/potassium-transporting ATPase inhibitor

    PMIDs:
    None found


  • Interaction Score: 1.72

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction Sodium/potassium-transporting ATPase inhibitor
    Direct Interaction yes

    PMIDs:
    None found


  • Interaction Score: 1.72

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Sodium/potassium-transporting ATPase inhibitor

    PMIDs:
    None found


  • Interaction Score: 1.37

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction Sodium/potassium-transporting ATPase inhibitor
    Direct Interaction yes

    PMIDs:
    None found


  • Interaction Score: 1.37

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction Sodium/potassium-transporting ATPase inhibitor
    Direct Interaction yes

    PMIDs:
    None found


  • Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

    • Version: 01-August-2011

    Alternate Names:
    DESLANOSIDE Primary Drug Name

    Drug Info:
    Drug Class anti-arrhythmia agents
    Drug Class cardiotonic agents
    Year of Approval approved before 1982

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications Antiarrhythmia Agents
    Drug Indications Cardiotonic Agents
    Drug Class small molecule

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D07TGN TTD Drug ID

    Drug Info:

    Publications:

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL1614 ChEMBL Drug ID

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: